You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 15, April 18, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Men's Health
 •Prostate Disease
 •Oncology
 •Prostate Cancer
 •Statistics and Research Methods
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Wong and colleagues1 report a statistically significant reduction in overall mortality with immediate surgery or radiation for low- to intermediate-risk prostate cancer. The absolute difference in overall mortality between the men receiving immediate treatment compared with no treatment was large (24% in the treatment group and 37% in the observation group). However, we question the validity of using overall mortality as an endpoint for measuring the anticancer treatment efficacy when the difference in prostate cancer-specific mortality over the 12-year study period was small (612 of 32 022 [1.9%] in the treatment group vs 314 of 12 608 [2.5%] in the observation group).

Contemporary treatment for localized prostate cancer is associated with a significant risk of long-term morbidity, including a 30% to 70% chance of erectile dysfunction and a 10% to 15% risk of incontinence.2 In this context, the clinical significance of a 0.6% absolute difference in cancer-specific survival . . . [Full Text of this Article]

Mark C. Scholz, MD
mark@prostateoncology.com

Richard Y. Lam, MD
Prostate Oncology Specialists, Inc
Marina del Rey, Calif

Laurence Klotz, MD, FRCSC
University of Toronto
Ontario



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Grace L. Lu-Yao, Michael J. Barry, Peter C. Albertsen, and Siu-Long Yao
JAMA. 2007;297(15):1651.
EXTRACT | FULL TEXT  

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
George A. Mark
JAMA. 2007;297(15):1652.
EXTRACT | FULL TEXT  

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Michael P. Porter
JAMA. 2007;297(15):1652.
EXTRACT | FULL TEXT  

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men—Reply
Yu-Ning Wong, Nandita Mitra, Gary Hudes, J. Sanford Schwartz, Fei Wan, Chantal Montagnet, and Katrina Armstrong
JAMA. 2007;297(15):1652-1653.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Yu-Ning Wong, Nandita Mitra, Gary Hudes, Russell Localio, J. Sanford Schwartz, Fei Wan, Chantal Montagnet, and Katrina Armstrong
JAMA. 2006;296(22):2683-2693.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.